E7-12056. Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry on Special Protocol Assessment  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

    DATES:

    Fax written comments on the collection of information by July 23, 2007.

    ADDRESSES:

    To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, FAX: 202-395-6974. All comments should be identified with the OMB control number 0910-0470. Also include the FDA docket number found in brackets in the heading of this document.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Elizabeth Berbakos, Office of the Chief Information Officer (HFA-250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857,301-827-1482.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance.

    Guidance for Industry on Special Protocol Assessment (OMB Control Number 0910-0470)—Extension

    In the Federal Register of July 31, 2006 (71 FR 43199), FDA published a 60-day notice requesting public comment on the information collection provisions. No comments were received.

    Table 1.—Estimated Annual Reporting Burden1

    21 CFR SectionNo. of RespondentsAnnual Frequency per ResponseTotal Annual ResponsesHours per ResponseTotal Hours
    Notification for Carcinogenicity Protocols212.19468368
    Requests for Special Protocol Assessment1512.48374155,610
    Total5,978
    1 There are no capital costs or operating and maintenance costs associated with this collection of information.
    Start Signature
    Start Printed Page 34471

    Dated: June 15, 2007.

    Jeffrey Shuren,

    Assistant Commissioner for Policy.

    End Signature End Supplemental Information

    [FR Doc. E7-12056 Filed 6-21-07; 8:45 am]

    BILLING CODE 4160-01-S

Document Information

Published:
06/22/2007
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
E7-12056
Dates:
Fax written comments on the collection of information by July 23, 2007.
Pages:
34470-34471 (2 pages)
Docket Numbers:
Docket No. 2000D-0084
PDF File:
e7-12056.pdf